Literature DB >> 18694819

Differential regulation of apoptosis by caspase-mediated cleavage of phospholipase D isozymes.

Young Hoon Jang1, Bong-Hyun Ahn, Seung Namkoong, Young Myeong Kim, Jae-Kwang Jin, Yong-Sun Kim, Do Sik Min.   

Abstract

Phospholipase D (PLD) has been implicated in survival and anti-apoptosis, but the molecular mechanism by which it responds to apoptotic stimuli is poorly unknown. Here, we demonstrate that cleavage of PLD isozymes as specific substrates of caspase differentially regulates apoptosis. PLD1 is cleaved at one internal site (DDVD(545)S) and PLD2 is cleaved at two or three sites (PTGD(13)ELD(16)S and DEVD(28)T) in the front of N-terminus. Cleavage of PLD was endogenously detected in post-mortem Alzheimer brain together with activated caspase-3, suggesting the physiological relevance. The cleavage of PLD1 but not PLD2 might act as an inactivating process since PLD1 but not PLD2 activity is significantly decreased during apoptosis, suggesting that differential cleavage of PLD isozymes could affect its enzymatic activity. Moreover, caspase-resistant mutant of PLD1 showed more potent anti-apoptotic capacity than that of wild type PLD1, whereas PLD2 maintained anti-apoptotic potency in spite of its cleavage during apoptosis. Moreover, PLD2 showed more potent anti-apoptotic effect than that of PLD1 in overexpression and knockdown experiments, suggesting that difference in anti-apoptotic potency between PLD1 and PLD2 might be due to its intrinsic protein property. Taken together, our results demonstrate that differential cleavage pattern of PLD isozymes by caspase might affect its enzymatic activity and anti-apoptotic function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694819     DOI: 10.1016/j.cellsig.2008.07.010

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  10 in total

Review 1.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 2.  Phospholipase D in brain function and Alzheimer's disease.

Authors:  Tiago Gil Oliveira; Gilbert Di Paolo
Journal:  Biochim Biophys Acta       Date:  2010-04-23

3.  Phospholipase D-mediated autophagic regulation is a potential target for cancer therapy.

Authors:  Y H Jang; K Y Choi; D S Min
Journal:  Cell Death Differ       Date:  2013-12-06       Impact factor: 15.828

Review 4.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

5.  The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-α.

Authors:  Xiaojia Ren; Jeriel T R Keeney; Sumitra Miriyala; Teresa Noel; David K Powell; Luksana Chaiswing; Subbarao Bondada; Daret K St Clair; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2018-12-26       Impact factor: 7.376

Review 6.  Phospholipase D and Its Essential Role in Cancer.

Authors:  Ju Hwan Cho; Joong-Soo Han
Journal:  Mol Cells       Date:  2017-11-16       Impact factor: 5.034

Review 7.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

8.  Role of phospholipase d in g-protein coupled receptor function.

Authors:  Lars-Ove Brandenburg; Thomas Pufe; Thomas Koch
Journal:  Membranes (Basel)       Date:  2014-07-03

9.  PED/PEA-15 inhibits hydrogen peroxide-induced apoptosis in Ins-1E pancreatic beta-cells via PLD-1.

Authors:  Francesca Fiory; Luca Parrillo; Gregory Alexander Raciti; Federica Zatterale; Cecilia Nigro; Paola Mirra; Roberta Falco; Luca Ulianich; Bruno Di Jeso; Pietro Formisano; Claudia Miele; Francesco Beguinot
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

10.  Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.

Authors:  Rita Cacace; Tobi Van den Bossche; Sebastiaan Engelborghs; Nathalie Geerts; Annelies Laureys; Lubina Dillen; Caroline Graff; Håkan Thonberg; Huei-Hsin Chiang; Pau Pastor; Sara Ortega-Cubero; Maria A Pastor; Janine Diehl-Schmid; Panagiotis Alexopoulos; Luisa Benussi; Roberta Ghidoni; Giuliano Binetti; Benedetta Nacmias; Sandro Sorbi; Raquel Sanchez-Valle; Albert Lladó; Ellen Gelpi; Maria Rosário Almeida; Isabel Santana; Magda Tsolaki; Maria Koutroumani; Jordi Clarimon; Alberto Lleó; Juan Fortea; Alexandre de Mendonça; Madalena Martins; Barbara Borroni; Alessandro Padovani; Radoslav Matej; Zdenek Rohan; Mathieu Vandenbulcke; Rik Vandenberghe; Peter P De Deyn; Patrick Cras; Julie van der Zee; Kristel Sleegers; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2015-10-14       Impact factor: 4.878

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.